Quarterly Activity Chart
Adds vs. Reduces by Quarter
PaperPanda Equity Terminal
LCTX —
LINEAGE CELL THERAPEUTICS IN
CUSIP: 53566P109 · Held by 2 superinvestors · Combined value: $4,907,382
Latest News
Loading financials…
| # | Investor | % of Portfolio | Value ($) | Shares | Recent Activity | Share Change |
|---|---|---|---|---|---|---|
| 1 | Jim Simons | 0.0% | $4,016,016 | 2,404,800 | ADD | +499,167 |
| 2 | Ken Griffin | 0.0% | $891,366 | 533,752 | ADD | +200,884 |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Jim Simons | ADD | +499,167 | +26.2% |
| Ken Griffin | ADD | +200,884 | +60.3% |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Jim Simons | REDUCE | -66,702 | -3.4% |
| Ken Griffin | REDUCE | -88,013 | -20.9% |
Who Owns LCTX? Superinvestor Holdings
LINEAGE CELL THERAPEUTICS IN is held by 2 tracked superinvestors, with a combined position value of $5 million . The largest positions are held by Jim Simons (0.0% of portfolio), Ken Griffin (0.0% of portfolio).
In the most recent quarter, 2 superinvestors added or initiated positions.